Wegener's granulomatosis and pulmonary vasculitis

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The most frequent types of systemic vasculitis to affect the lung are Wegener's granulomatosis, microscopic polyangiitis, and the Churg-Strauss syndrome. Although all three typically affect the small vessels, Wegener's granulomatosis and, frequently, Churg-Strauss syndrome have characteristic necrotizing granulomatous features. All three syndromes lack immune complex deposits but are associated with anti-neutrophil cytoplasmic antibodies, which have been implicated in their pathogenesis. The initial disease phase of Wegener's granulomatosis is usually dominated by symptoms resulting from the necrotizing granulomatous inflammation affecting the respiratory tract. This initial phase frequently responds to trimethoprim-sulfamethoxazole. During the generalized vasculitic phase of Wegener's granulomatosis, immunosuppression with the standard regimen consisting of oral prednisone and cyclophosphamide is required. Alternative immunosuppressive regimens have been tried because of the high toxicity rate of the standard regimen. Plasma exchange and, most recently, intravenous immunoglobulin have been used in patients not responding to standard immunosuppression with mixed results. Most cases of Churg-Strauss syndrome respond promptly to oral glucocorticoids alone.

Original languageEnglish (US)
Pages (from-to)267-275
Number of pages9
JournalClinical Pulmonary Medicine
Volume2
Issue number5
StatePublished - 1995

Fingerprint

Granulomatosis with Polyangiitis
Vasculitis
Churg-Strauss Syndrome
Lung
Immunosuppression
Microscopic Polyangiitis
Systemic Vasculitis
Antineutrophil Cytoplasmic Antibodies
Plasma Exchange
Intravenous Immunoglobulins
Sulfamethoxazole Drug Combination Trimethoprim
Immunosuppressive Agents
Prednisone
Antigen-Antibody Complex
Respiratory System
Cyclophosphamide
Glucocorticoids
Inflammation

Keywords

  • Anti-neutrophil cytoplasmic antibody
  • Churg-Strauss syndrome
  • Microscopic polyangiitis
  • Pulmonary vasculitis
  • Wegener's granulomatosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Wegener's granulomatosis and pulmonary vasculitis. / Specks, Ulrich.

In: Clinical Pulmonary Medicine, Vol. 2, No. 5, 1995, p. 267-275.

Research output: Contribution to journalArticle

@article{9df843dbf0a546629e17e61d0b031a95,
title = "Wegener's granulomatosis and pulmonary vasculitis",
abstract = "The most frequent types of systemic vasculitis to affect the lung are Wegener's granulomatosis, microscopic polyangiitis, and the Churg-Strauss syndrome. Although all three typically affect the small vessels, Wegener's granulomatosis and, frequently, Churg-Strauss syndrome have characteristic necrotizing granulomatous features. All three syndromes lack immune complex deposits but are associated with anti-neutrophil cytoplasmic antibodies, which have been implicated in their pathogenesis. The initial disease phase of Wegener's granulomatosis is usually dominated by symptoms resulting from the necrotizing granulomatous inflammation affecting the respiratory tract. This initial phase frequently responds to trimethoprim-sulfamethoxazole. During the generalized vasculitic phase of Wegener's granulomatosis, immunosuppression with the standard regimen consisting of oral prednisone and cyclophosphamide is required. Alternative immunosuppressive regimens have been tried because of the high toxicity rate of the standard regimen. Plasma exchange and, most recently, intravenous immunoglobulin have been used in patients not responding to standard immunosuppression with mixed results. Most cases of Churg-Strauss syndrome respond promptly to oral glucocorticoids alone.",
keywords = "Anti-neutrophil cytoplasmic antibody, Churg-Strauss syndrome, Microscopic polyangiitis, Pulmonary vasculitis, Wegener's granulomatosis",
author = "Ulrich Specks",
year = "1995",
language = "English (US)",
volume = "2",
pages = "267--275",
journal = "Clinical Pulmonary Medicine",
issn = "1068-0640",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Wegener's granulomatosis and pulmonary vasculitis

AU - Specks, Ulrich

PY - 1995

Y1 - 1995

N2 - The most frequent types of systemic vasculitis to affect the lung are Wegener's granulomatosis, microscopic polyangiitis, and the Churg-Strauss syndrome. Although all three typically affect the small vessels, Wegener's granulomatosis and, frequently, Churg-Strauss syndrome have characteristic necrotizing granulomatous features. All three syndromes lack immune complex deposits but are associated with anti-neutrophil cytoplasmic antibodies, which have been implicated in their pathogenesis. The initial disease phase of Wegener's granulomatosis is usually dominated by symptoms resulting from the necrotizing granulomatous inflammation affecting the respiratory tract. This initial phase frequently responds to trimethoprim-sulfamethoxazole. During the generalized vasculitic phase of Wegener's granulomatosis, immunosuppression with the standard regimen consisting of oral prednisone and cyclophosphamide is required. Alternative immunosuppressive regimens have been tried because of the high toxicity rate of the standard regimen. Plasma exchange and, most recently, intravenous immunoglobulin have been used in patients not responding to standard immunosuppression with mixed results. Most cases of Churg-Strauss syndrome respond promptly to oral glucocorticoids alone.

AB - The most frequent types of systemic vasculitis to affect the lung are Wegener's granulomatosis, microscopic polyangiitis, and the Churg-Strauss syndrome. Although all three typically affect the small vessels, Wegener's granulomatosis and, frequently, Churg-Strauss syndrome have characteristic necrotizing granulomatous features. All three syndromes lack immune complex deposits but are associated with anti-neutrophil cytoplasmic antibodies, which have been implicated in their pathogenesis. The initial disease phase of Wegener's granulomatosis is usually dominated by symptoms resulting from the necrotizing granulomatous inflammation affecting the respiratory tract. This initial phase frequently responds to trimethoprim-sulfamethoxazole. During the generalized vasculitic phase of Wegener's granulomatosis, immunosuppression with the standard regimen consisting of oral prednisone and cyclophosphamide is required. Alternative immunosuppressive regimens have been tried because of the high toxicity rate of the standard regimen. Plasma exchange and, most recently, intravenous immunoglobulin have been used in patients not responding to standard immunosuppression with mixed results. Most cases of Churg-Strauss syndrome respond promptly to oral glucocorticoids alone.

KW - Anti-neutrophil cytoplasmic antibody

KW - Churg-Strauss syndrome

KW - Microscopic polyangiitis

KW - Pulmonary vasculitis

KW - Wegener's granulomatosis

UR - http://www.scopus.com/inward/record.url?scp=0029114690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029114690&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 267

EP - 275

JO - Clinical Pulmonary Medicine

JF - Clinical Pulmonary Medicine

SN - 1068-0640

IS - 5

ER -